Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05035745
Brief Title: Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

First Submitted : March 1, 2021
First Submitted that Met QC Criteria : August 31, 2021
First Posted : September 5, 2021

Last Update Submitted that Met QC Criteria : August 31, 2021
Last Update Posted : September 5, 2021